DocDollars

Dynavax Technologies Corporation

CA · United States · Reporting entity ID 100000291836

Total reported 2019–2025
$21.3M
#306 of 2,960 reporting companies — 0% of all reported industry payments
$2.42M in general payments across 21,485 records, plus $18.9M in research funding across 1,538 records.

How it breaks down

General payments $2,418,266
Research funding $18,873,355

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Dynavax Technologies Corporation reported $21.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #306 of 2,960 reporting companies. 89% of that was research funding and 11% general payments such as consulting, speaking, food and travel. 21,485 general payment records and 1,538 research records were filed.

Common questions about Dynavax Technologies Corporation

How much has Dynavax Technologies Corporation paid US doctors?

Dynavax Technologies Corporation reported $21,291,621 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,418,266 in general payments, $18,873,355 in research funding.

How does Dynavax Technologies Corporation rank among drug and device companies?

It ranks #306 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Dynavax Technologies Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.